Using blueprint to elucidate the molecular heterogeneity of triple negative breast cancers

Category Primary study
JournalCancer Research
Year 2021
This article has no abstract
Epistemonikos ID: f1abd018c67ce7a28228b872eb58f50409336b10
First added on: Feb 12, 2025